Vaxxinity (VAXX) Institutional Ownership → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free VAXX Stock Alerts $0.11 -0.02 (-15.26%) (As of 05/8/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Vaxxinity (NASDAQ:VAXX)CurrentInstitutional OwnershipPercentage82.95%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$197.55KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$57.06K Get VAXX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaxxinity stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VAXX Institutional Buying and Selling by Quarter Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. Vaxxinity Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/7/2024Ieq Capital LLC83,262$71K0.0%N/A0.066% 11/7/2023New York State Common Retirement Fund23,642$32K0.0%-46.4%0.019% 10/31/2023 McAdam LLC68,281$94K0.0%+47.4%0.054% 10/24/2023 Bank of New York Mellon Corp121,522$166K0.0%-14.8%0.096% 10/19/2023 Clarius Group LLC20,000$27K0.0%N/A0.016% 8/4/2023American International Group Inc.20,514$52K0.0%N/A0.016% 7/25/2023 Raymond James Financial Services Advisors Inc.17,001$43K0.0%+69.7%0.013% 5/3/2023Integrated Wealth Concepts LLC11,000$25K0.0%N/A0.009% 5/2/2023 Lincoln National Corp41,070$93K0.0%N/A0.033% 5/1/2023Virtu Financial LLC12,263$28K0.0%-31.3%0.010% 4/24/2023 McAdam LLC46,324$105K0.0%N/A0.037% 4/21/2023 Blue Zone Wealth Advisors LLC27,500$62K0.0%N/A0.022% 4/18/2023ETF Managers Group LLC43,836$100K0.0%+39.5%0.035% 3/23/2023ETF Managers Group LLC31,427$44K0.0%-15.5%0.025% 11/15/2022Prime Movers Lab LLC17,603,276$31.37M22.6%-1.4%13.968% 11/4/2022First Republic Investment Management Inc.199,022$394K0.0%N/A0.158% 8/10/2022 Clarius Group LLC20,000$31K0.0%N/A0.016% 7/22/2022Truist Financial Corp20,738$33K0.0%N/A0.016% 7/21/2022 Hollencrest Capital Management20,000$31K0.0%N/A0.016% 3/10/2022Prime Movers Lab LLC18,027,314$91.02M17.4%N/A14.377% 2/15/2022Adage Capital Partners GP L.L.C.1,001,670$5.62M0.0%N/A0.799% 2/14/2022ETF Managers Group LLC37,884$211K0.0%N/A0.030% 2/1/2022 FNY Investment Advisers LLC4,847$27K0.0%N/A0.004% (Data available from 1/1/2016 forward) VAXX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VAXX shares? During the previous two years, 16 institutional investors and hedge funds held shares of Vaxxinity. The most heavily invested institutionals were Prime Movers Lab LLC ($31.37M), First Republic Investment Management Inc. ($394K), Bank of New York Mellon Corp ($166K), ETF Managers Group LLC ($100K), McAdam LLC ($94K), Lincoln National Corp ($93K), and Ieq Capital LLC ($71K).Learn more on VAXX's institutional investors. What percentage of Vaxxinity stock is owned by institutional investors? 82.95% of Vaxxinity stock is owned by institutional investors. Learn more on VAXX's institutional investor holdings. Which institutional investors have been buying Vaxxinity stock? Of the 12 institutional investors that purchased Vaxxinity stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: First Republic Investment Management Inc. ($199.02K), Ieq Capital LLC ($83.26K), McAdam LLC ($68.28K), Lincoln National Corp ($41.07K), Clarius Group LLC ($40K), Blue Zone Wealth Advisors LLC ($27.50K), and Truist Financial Corp ($20.74K). How much institutional buying is happening at Vaxxinity? Institutional investors have bought a total of 550,781 shares in the last 24 months. This purchase volume represents approximately $1.00M in transactions. Which Vaxxinity major shareholders have been selling company stock? The following institutional investors have sold Vaxxinity stock in the last 24 months: Prime Movers Lab LLC ($245.04K), Bank of New York Mellon Corp ($21.19K), New York State Common Retirement Fund ($20.46K), ETF Managers Group LLC ($5.76K), and Virtu Financial LLC ($5.58K). How much institutional selling is happening at Vaxxinity? Institutional investors have sold a total of 298,030 shares in the last 24 months. This volume of shares sold represents approximately $562.97K in transactions. Related Companies: Aytu BioPharma Institutional Ownership Tonix Pharmaceuticals Institutional Ownership FSD Pharma Institutional Ownership VBI Vaccines Institutional Ownership Minerva Neurosciences Institutional Ownership Pieris Pharmaceuticals Institutional Ownership Edesa Biotech Institutional Ownership Avalo Therapeutics Institutional Ownership Vincerx Pharma Institutional Ownership Kiora Pharmaceuticals Institutional Ownership This page (NASDAQ:VAXX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxxinity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.